PFIZER INC Annual Income Tax Expense (Benefit) in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pfizer Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Pfizer Inc Income Tax Expense (Benefit) for the quarter ending September 29, 2024 was $234M.
- Pfizer Inc Income Tax Expense (Benefit) for the twelve months ending September 29, 2024 was -$402M, a 347% decline year-over-year.
- Pfizer Inc annual Income Tax Expense (Benefit) for 2023 was -$1.12B, a 134% decline from 2022.
- Pfizer Inc annual Income Tax Expense (Benefit) for 2022 was $3.33B, a 79.7% increase from 2021.
- Pfizer Inc annual Income Tax Expense (Benefit) for 2021 was $1.85B, a 401% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)